FDA Accelerates Action on Treatments for Serious Mental Illness Following Executive Order
Summary
Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders
Description
Agency issues priority vouchers, clears new clinical research, and advances guidance to support treatments for depression, PTSD, and substance use disorders
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source